Serina Therapeutics, Inc

SERAMEX · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

25.4M

on 2026-06-30, from 8.41M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2025-04-02. 1 prospectus supplement filed under it since. S-3 ↗

$25.0M

Roth Principal Investments, agreement of 2026-08-21. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

2.97M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

4.4 quarters

$23.0M on 2026-06-30 ÷ $5.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-04-08	Private placement	962,250	not read	$5.0M	8-K ↗

Also on file: up to $20.0M convertible notes agreed 2025-09-09 8-K ↗